Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy

被引：0
|
作者：
Elizabeth Hovey
Paul de Souza
Gavin Marx
Phillip Parente
Tal Rapke
Andrew Hill
Antonino Bonaventura
Antony Michele
Paul Craft
Ehtesham Abdi
Andrew Lloyd
机构：
[1] Prince of Wales Hospital,Department of Medical Oncology
[2] University of New South Wales,undefined
[3] University of Western Sydney,undefined
[4] Sydney Haematology Oncology Clinics,undefined
[5] Box Hill Hospital,undefined
[6] Sanofi Australia Pty Ltd,undefined
[7] Gold Coast Hospital,undefined
[8] ANZGOG,undefined
[9] Calvary Hospital,undefined
[10] The Canberra Hospital,undefined
[11] The Tweed Hospital,undefined
[12] Griffith University,undefined
来源：
Supportive Care in Cancer | 2014年 / 22卷
关键词：
Breast cancer; Docetaxel; Fatigue; Prostate cancer; Modafinil; Chemotherapy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1233 / 1242
页数：9
相关论文
共 50 条
  • [1] Phase III, randomized, double-blind, placebo-controlled study of modafinil for fatigue in patients treated with docetaxel-based chemotherapy
    Hovey, Elizabeth
    de Souza, Paul
    Marx, Gavin
    Parente, Phillip
    Rapke, Tal
    Hill, Andrew
    Bonaventura, Antonino
    Michele, Antony
    Craft, Paul
    Abdi, Ehtesham
    Lloyd, Andrew
    SUPPORTIVE CARE IN CANCER, 2014, 22 (05) : 1233 - 1242
  • [2] PHASE III, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MODAFINIL FOR FATIGUE IN PATIENTS TREATED WITH DOCETAXEL-BASED CHEMOTHERAPY
    Hovey, E.
    de Souza, P.
    Marx, G.
    Parente, P.
    Rapke, T.
    Hill, A.
    Bonaventura, A.
    Michele, A.
    Kraft, P.
    Lloyd, A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 26 - 26
  • [3] PHASE III, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF MODAFINIL FOR FATIGUE IN PATIENTS TREATED WITH DOCETAXEL-BASED CHEMOTHERAPY
    Hovey, E.
    de Souza, P.
    Marx, G.
    Parente, P.
    Rapke, T.
    Hill, A.
    Bonaventura, A.
    Michele, A.
    Kraft, P.
    Lloyd, A.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2012, 8 : 44 - 44
  • [4] Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study
    Rammohan, KW
    Lynn, DJ
    NEUROLOGY, 2005, 65 (12) : 1995 - 1996
  • [5] Modafinil for fatigue in MS - A randomized placebo-controlled double-blind study
    Stankoff, B
    Waubant, E
    Confavreux, C
    Edan, G
    Debouverie, M
    Rumbach, L
    Moreau, T
    Pelletier, J
    Lubetzki, C
    Clanet, M
    NEUROLOGY, 2005, 64 (07) : 1139 - 1143
  • [6] Modafinil for fatigue in MS: A randomized placebo-controlled double-blind study - Reply
    Stankoff, B
    Waubant, E
    Lubetzki, C
    Clanet, M
    NEUROLOGY, 2005, 65 (12) : 1996 - 1997
  • [7] Modafinil for fatigue associated with docetaxel-based chemotherapy: A randomized controlled trial
    Hovey, Elizabeth J.
    De Souza, Paul L.
    Marx, Gavin M.
    Parente, Phillip
    Rapke, Tal
    Hill, Andrew
    Bonaventura, Antonino
    Michele, Antonio
    Craft, Paul Stanley
    Abdi, Ehtesham A.
    Lloyd, Andrew R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [8] Double-blind, placebo-controlled study of modafinil for fatigue and cognition in schizophrenia patients treated with psychotropic medications
    Sevy, S
    Rosenthal, MH
    Alvir, J
    Meyer, S
    Visweswaraiah, H
    Gunduz-Bruce, H
    Schooler, NR
    JOURNAL OF CLINICAL PSYCHIATRY, 2005, 66 (07) : 839 - 843
  • [9] A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer
    Dreicer, Robert
    Garcia, Jorge
    Rini, Brian
    Vogelzang, Nicholas
    Srinivas, Sandy
    Somer, Bradley
    Shi, Peipei
    Kania, Marek
    Raghavan, Derek
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (04) : 1044 - 1050
  • [10] A randomized, double-blind, placebo-controlled, Phase II study with and without enzastaurin in combination with docetaxel-based chemotherapy in patients with castration-resistant metastatic prostate cancer
    Robert Dreicer
    Jorge Garcia
    Brian Rini
    Nicholas Vogelzang
    Sandy Srinivas
    Bradley Somer
    Peipei Shi
    Marek Kania
    Derek Raghavan
    Investigational New Drugs, 2013, 31 : 1044 - 1050
12345